GlassScriptPhysician profile
Baptiste S Marino
NPI 1104070820
$10,490.17
in general payments reported to CMS, 2019-2025
43 companies · $1,955 in 2025
The $1,955 reported for 2025 was more than what 96% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $678 · 2020: $648 · 2021: $1,834 · 2022: $2,024 · 2023: $2,239 · 2024: $1,111 · 2025: $1,955.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,305.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,362.61 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,878.32 | 2020-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $1,182.45 | 2020-2025 | Xtampza, Belbuca |
| Pfizer INC. | $567.63 | 2023-2025 | |
| Idorsia Pharmaceuticals US INC | $371.76 | 2022-2024 | Quviviq |
| Merck Sharp & Dohme LLC | $309.55 | 2022-2023 | Belsomra |
| Eisai INC. | $297.45 | 2021 | |
| Forte Bio-Pharma LLC | $285.60 | 2020-2025 | Prolate, Nalocet, Tanlor |
| Azurity Pharmaceuticals, INC. | $280.37 | 2023-2025 | Horizant, Horizant |
| Saluda Medical Americas, INC. | $269.55 | 2025 | Evoke |
| Boston Scientific Corporation | $204.51 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Biodelivery Sciences International, INC. | $198.82 | 2019-2021 | |
| Daiichi Sankyo INC. | $186.48 | 2019 | |
| Arbor Pharmaceuticals, INC. | $170.32 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $162.12 | 2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Baptiste Marino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.